Innovative Clinical Science. Improved Patient Care.


We focus our research and development practice on discovering and developing new medicines for unmet medical needs. Right now, the Genentech Research and Early Development pipeline has more than 20 new molecular entities in clinical development.

Building a Body of Evidence: Translational Medicine

PlayPlay03:08

Sometimes the science in the laboratory doesn't exactly play out as we predicted in clinical trials. So we spend time refining our approach in the lab and in the clinic.

Investigator Initiated Studies (IIS)

Researchers are invited to submit their concept proposal via the IIS submission portal.

Clinical Fellowships

Our immunology program offers the experience needed to transform knowledge into practice

Approvals Timeline

A look at our approvals past and present.

Understanding Antibody-Drug Conjugates

Medical Information for HCPs

This convenient resource offers scientific and clinical information for US healthcare providers.

Help Your Patients

Genentech Access Solutions offers your patients coverage support, assistance, other useful information.

Our Founders

Bob Swanson & Herb Boyer started the company that launched an industry.

Understanding Reimbursement

Information reimbursement denials and appeals as well as billing and coding.

Most Innovative in 2012

We've been named to Fast Company's list of "The World's 50 Most Innovative Companies" list for making targeted, genetics-based cancer therapies.

Gene Expressions

This video series explores ongoing research by our scientists in a variety of focus areas. Watch it on YouTube.

Support for Independent Medical Education

We support grants for independent medical education to further the advance of medicine and healthcare.
Load More  

By The Numbers

38
Medicines on the market
48
Molecules in our pipeline
785K
Square feet devoted to research